Clinical Trial Update: Use of an Oxidized Regenerated Cellulose After Hepatic Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial sponsored by Fudan University is evaluating the use of oxidized regenerated cellulose after hepatic surgery for liver neoplasms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms

Snippet

Sponsor: Fudan University | Conditions: Liver Neoplasms | Phase 2, Phase 3 | Status: UNKNOWN